These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 22981677

  • 1. Effects of mirabegron, a novel β3-adrenoceptor agonist, on primary bladder afferent activity and bladder microcontractions in rats compared with the effects of oxybutynin.
    Aizawa N, Homma Y, Igawa Y.
    Eur Urol; 2012 Dec; 62(6):1165-73. PubMed ID: 22981677
    [Abstract] [Full Text] [Related]

  • 2. Effects of L-arginine, mirabegron, and oxybutynin on the primary bladder afferent nerve activities synchronized with reflexic, rhythmic bladder contractions in the rat.
    Aizawa N, Homma Y, Igawa Y.
    Neurourol Urodyn; 2015 Apr; 34(4):368-74. PubMed ID: 24532414
    [Abstract] [Full Text] [Related]

  • 3. Functional roles of bladder α1-adrenoceptors in the activation of single-unit primary bladder afferent activity in rats.
    Aizawa N, Sugiyama R, Ichihara K, Fujimura T, Fukuhara H, Homma Y, Igawa Y.
    BJU Int; 2016 Jun; 117(6):993-1001. PubMed ID: 26332379
    [Abstract] [Full Text] [Related]

  • 4. The role of transient receptor potential ankyrin 1 (TRPA1) channel in activation of single unit mechanosensitive bladder afferent activities in the rat.
    Minagawa T, Aizawa N, Igawa Y, Wyndaele JJ.
    Neurourol Urodyn; 2014 Jun; 33(5):544-9. PubMed ID: 23784920
    [Abstract] [Full Text] [Related]

  • 5. Systemic oxybutynin decreases afferent activity of the pelvic nerve of the rat: new insights into the working mechanism of antimuscarinics.
    De Laet K, De Wachter S, Wyndaele JJ.
    Neurourol Urodyn; 2006 Jun; 25(2):156-61. PubMed ID: 16372316
    [Abstract] [Full Text] [Related]

  • 6. Modulation of non-voiding activity by the muscarinergic antagonist tolterodine and the β(3)-adrenoceptor agonist mirabegron in conscious rats with partial outflow obstruction.
    Gillespie JI, Palea S, Guilloteau V, Guerard M, Lluel P, Korstanje C.
    BJU Int; 2012 Jul; 110(2 Pt 2):E132-42. PubMed ID: 22734512
    [Abstract] [Full Text] [Related]

  • 7. Selective inhibitory effect of imidafenacin and 5-hydroxymethyl tolterodine on capsaicin sensitive C fibers of the primary bladder mechanosensitive afferent nerves in the rat.
    Aizawa N, Ito H, Sugiyama R, Fujimura T, Suzuki M, Fukuhara H, Homma Y, Igawa Y.
    J Urol; 2015 Apr; 193(4):1423-32. PubMed ID: 25219701
    [Abstract] [Full Text] [Related]

  • 8. Effects of the M3 receptor selective muscarinic antagonist darifenacin on bladder afferent activity of the rat pelvic nerve.
    Iijima K, De Wachter S, Wyndaele JJ.
    Eur Urol; 2007 Sep; 52(3):842-7. PubMed ID: 17360104
    [Abstract] [Full Text] [Related]

  • 9. Inhibitory effects of phosphodiesterase 5 inhibitor, tadalafil, on mechanosensitive bladder afferent nerve activities of the rat, and on acrolein-induced hyperactivity of these nerves.
    Minagawa T, Aizawa N, Igawa Y, Wyndaele JJ.
    BJU Int; 2012 Sep; 110(6 Pt B):E259-66. PubMed ID: 22591258
    [Abstract] [Full Text] [Related]

  • 10. Inhibitory effects of silodosin on the bladder mechanosensitive afferent activities and their relation with bladder myogenic contractions in male rats with bladder outlet obstruction.
    Aizawa N, Watanabe D, Fukuhara H, Fujimura T, Kume H, Homma Y, Igawa Y.
    Neurourol Urodyn; 2018 Aug; 37(6):1897-1903. PubMed ID: 29508437
    [Abstract] [Full Text] [Related]

  • 11. Intravesical oxybutynin: a local anesthetic effect on bladder C afferents.
    De Wachter S, Wyndaele JJ.
    J Urol; 2003 May; 169(5):1892-5. PubMed ID: 12686868
    [Abstract] [Full Text] [Related]

  • 12. Effect of mirabegron, a novel β3-adrenoceptor agonist, on bladder function during storage phase in rats.
    Hatanaka T, Ukai M, Watanabe M, Someya A, Ohtake A, Suzuki M, Ueshima K, Sato S, Kaku S.
    Naunyn Schmiedebergs Arch Pharmacol; 2013 Jan; 386(1):71-8. PubMed ID: 23224420
    [Abstract] [Full Text] [Related]

  • 13. Protective effect of a β3-adrenoceptor agonist on bladder function in a rat model of chronic bladder ischemia.
    Sawada N, Nomiya M, Hood B, Koslov D, Zarifpour M, Andersson KE.
    Eur Urol; 2013 Oct; 64(4):664-71. PubMed ID: 23838637
    [Abstract] [Full Text] [Related]

  • 14. Characteristics of the mechanosensitive bladder afferent activities in relation with microcontractions in male rats with bladder outlet obstruction.
    Aizawa N, Ichihara K, Fukuhara H, Fujimura T, Andersson KE, Homma Y, Igawa Y.
    Sci Rep; 2017 Aug 09; 7(1):7646. PubMed ID: 28794457
    [Abstract] [Full Text] [Related]

  • 15. Combinational effects of muscarinic receptor inhibition and β3-adrenoceptor stimulation on neurogenic bladder dysfunction in rats with spinal cord injury.
    Wada N, Shimizu T, Takai S, Shimizu N, Tyagi P, Kakizaki H, Yoshimura N.
    Neurourol Urodyn; 2017 Apr 09; 36(4):1039-1045. PubMed ID: 27367752
    [Abstract] [Full Text] [Related]

  • 16. Effects of TRPV4 cation channel activation on the primary bladder afferent activities of the rat.
    Aizawa N, Wyndaele JJ, Homma Y, Igawa Y.
    Neurourol Urodyn; 2012 Jan 09; 31(1):148-55. PubMed ID: 22038643
    [Abstract] [Full Text] [Related]

  • 17. Mechanisms of pelvic organ cross-talk: 2. Impact of colorectal distention on afferent nerve activity of the rat bladder.
    Minagawa T, Wyndaele M, Aizawa N, Igawa Y, Wyndaele JJ.
    J Urol; 2013 Sep 09; 190(3):1123-30. PubMed ID: 23542407
    [Abstract] [Full Text] [Related]

  • 18. Effects of Sildenafil, a Phosphodiesterase Type 5 Inhibitor, on the Primary Single Afferent Activity of the Rat Bladder.
    Aizawa N, Ito H, Sugiyama R, Fujimura T, Fukuhara H, Kume H, Homma Y, Igawa Y.
    Low Urin Tract Symptoms; 2017 Jan 09; 9(1):57-61. PubMed ID: 28120447
    [Abstract] [Full Text] [Related]

  • 19. Inhibitory effects of vibegron, a β3-adrenoceptor agonist, on the myogenic contractile and mechanosensitive afferent activities in an obstructed rat bladder.
    Aizawa N, Fujita T.
    Eur J Pharmacol; 2022 Oct 15; 933():175272. PubMed ID: 36108733
    [Abstract] [Full Text] [Related]

  • 20. The novel β3-adrenoceptor agonist mirabegron reduces carbachol-induced contractile activity in detrusor tissue from patients with bladder outflow obstruction with or without detrusor overactivity.
    Svalø J, Nordling J, Bouchelouche K, Andersson KE, Korstanje C, Bouchelouche P.
    Eur J Pharmacol; 2013 Jan 15; 699(1-3):101-5. PubMed ID: 23246623
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.